Transcriptomics

Dataset Information

59

Transcriptome Analysis Identifies Fn14, a TNF Superfamily Receptor Member, as a Therapeutic Target in Alcoholic Hepatitis


ABSTRACT: Alcoholic hepatitis (AH) is the most severe form of alcoholic liver disease and occurs in patients with excessive alcohol intake It is characterized by marked hepatocellular damage, steatosis and pericellular fibrosis. Patients with severe AH have a poor short-term prognosis. Unfortunately, current therapies (i.e. corticosteroids and pentoxyphylline) are not effective in many patients and novel targeted therapies are urgently needed. The development of such therapies is hampered by a poor knowledge of the underlying molecular mechanisms. Based on studies from animal models, TNF alfa was proposed to play a pivotal role in the mechanisms of AH. Consequently, drugs interfering TNF alfa were tested in these patients. The results were disappointing due to an increased incidence of severe infections. Unluckily, there are not experimental models that mimic the main findings of AH in humans. To overcome this limitation, translational studies with human samples are required. We previously analyzed samples from patients with biopsy-proven AH. In these previous studies, we identified CXC chemokines as a potential therapeutic target for these patients. We expanded these previous observations by performing a high-throughout transcriptome analysis. Hepatic gene expression profiling was assessed by DNA microarray in patients with Alcoholic hepatitis (n=15) and normal livers (n=7).

ORGANISM(S): Homo sapiens  

SUBMITTER: A Loaeza  P Ginès   Juanjo Lozano   D Rodrigo-Torres   J Caballería   O Morales-Ibanez   J Altamirano   M Dominguez   M Moreno   C Millán   P Sancho-Bru   J J Lozano   V Arroyo   J C Garcia-Pagán   R Bataller   S Affo    

PROVIDER: E-GEOD-28619 | ArrayExpress| 2012-06-26

SECONDARY ACCESSION(S): GSE28619PRJNA138739

REPOSITORIES: GEO, ArrayExpress

altmetric image

Publications


Alcoholic hepatitis (AH) is a severe clinical condition that needs novel therapies. The identification of targets for therapy is hampered by the lack of animal models of advanced AH. The authors performed a translational study through a transcriptome analysis in patients with AH to identify new molecular targets.Hepatic gene expression profiling was assessed by DNA microarray in patients with AH (n=15) and normal livers (n=7). Functional analysis was assessed by gene set enrichment analysis. Qua  ...[more]

Similar Datasets

2012-06-15 | GSE28619 | GEO
| GSE103580 | GEO
| GSE94399 | GEO
| GSE94397 | GEO
| GSE97234 | GEO
| GSE95246 | GEO
2016-08-06 | E-GEOD-59492 | ArrayExpress
2018-09-05 | GSE119470 | GEO
| GSE67546 | GEO
| GSE119953 | GEO